Yield10 Bioscience Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2002
Revenue	0.06	0.45	0.61	0.8	0.81	Upgrade
Revenue Growth (YoY)	-86.67%	-26.71%	-23.15%	-0.87%	44.96%	Upgrade
Cost of Revenue	0.29	0.66	0.58	5.22	4.85	Upgrade
Gross Profit	-0.23	-0.21	0.04	-4.42	-4.04	Upgrade
Selling, General & Admin	5.86	6.15	6.11	5.05	4.55	Upgrade
Research & Development	8.32	7.75	6.2	5.36	4.85	Upgrade
Other Operating Expenses	-0.04	0.04	-0	0.08	0.02	Upgrade
Operating Expenses	14.19	13.9	12.31	10.41	9.4	Upgrade
Operating Income	-14.42	-13.45	-11.69	-9.61	-8.6	Upgrade
Interest Income	0	0	0	0	0.1	Upgrade
Interest Expense	0	-0.04	0	0	13.02	Upgrade
Other Expense / Income	0.04	-	-0.7	0.54	-8.31	Upgrade
Pretax Income	-14.46	-13.41	-11	-10.15	-13.21	Upgrade
Income Tax	0	0.16	0.04	0.06	-0.25	Upgrade
Net Income	-14.46	-13.57	-11.03	-10.21	-12.96	Upgrade
Shares Outstanding (Basic)	0	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	0	0	0	0	0	Upgrade
Shares Change	61.69%	3.86%	99.38%	550.27%	46.98%	Upgrade
EPS (Basic)	-43.66	-66.25	-55.95	-103.21	-851.98	Upgrade
EPS (Diluted)	-43.66	-66.25	-55.95	-103.21	-851.98	Upgrade
Free Cash Flow	-10.11	-11.56	-9.44	-8.74	-8.72	Upgrade
Free Cash Flow Per Share	-30.55	-56.44	-47.89	-88.33	-573.09	Upgrade
Gross Margin	-383.33%	-45.78%	5.86%	-553.32%	-501.49%	Upgrade
Operating Margin	-24028.33%	-2989.11%	-1904.23%	-1202.63%	-1066.50%	Upgrade
Profit Margin	-24091.67%	-3014.67%	-1796.58%	-1277.35%	-1607.44%	Upgrade
Free Cash Flow Margin	-16856.67%	-2568.44%	-1537.79%	-1093.24%	-1081.27%	Upgrade
EBITDA	-14.13	-13.19	-12.17	-8.8	-4.92	Upgrade
EBITDA Margin	-23545.00%	-2930.67%	-1982.41%	-1101.75%	-609.93%	Upgrade
Depreciation & Amortization	0.29	0.26	0.22	0.18	0.2	Upgrade
EBIT	-14.42	-13.45	-12.39	-8.99	-5.12	Upgrade
EBIT Margin	-24028.33%	-2989.11%	-2018.24%	-1124.53%	-635.11%	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.